MAP1LC3A and metabolic dysfunction-associated steatotic liver disease: The strength of these non-covalent bonds between lipid molecules may provide resistance to and down regulation of effective lipophagy, thereby offering an alternative explanation for the lack of MAP1LC3A expression in NAFLD samples.